SC 13G/A
Amended Statement of Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001193125-19-018824
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| BB Biotech AG | 2,978,134 | 5.12% |
| Biotech Target N.V. N/A | 2,978,134 | 5.12% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
- 2026-11-16 SCHEDULE 13G/A · D. E. Shaw & Co., L.P. 6.5%
- 2026-11-16 SCHEDULE 13G/A · Lynx1 Capital Management LP 0.8%
- 2026-11-13 SCHEDULE 13G · Morgan Stanley 5.7%
- 2025-06-13 SCHEDULE 13G/A · BB Biotech AG 0%
- 2025-02-14 SCHEDULE 13G/A · BB Biotech AG 6.2%
- 2024-02-13 SC 13G/A · BB Biotech AG 7.2%
- 2023-02-14 SC 13G/A · BB Biotech AG 7.3%
- 2022-02-11 SC 13G/A · BB Biotech AG 7.9%
- 2021-02-12 SC 13G/A · BB Biotech AG 6.0%
- 2020-02-14 SC 13G/A · BB Biotech AG 5.7%
- 2019-01-28 SC 13G/A · BB Biotech AG 5.12%
- 2018-02-14 SC 13G/A · BB Biotech AG 5.6%
- 2017-02-14 SC 13G/A · BB Biotech AG 6.7%
- 2016-02-09 SC 13G/A · BB Biotech AG 5.7%
- 2015-02-12 SC 13G/A · BB Biotech AG 5.1%
- 2014-09-11 SC 13G · BB Biotech AG 5.1%
Loading d697775dsc13ga.htm…